Lars Wallentin

Author PubWeight™ 3.00^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.	Eur Heart J	2014	2.32
2	Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.	Eur J Prev Cardiol	2014	0.79
3	Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.	Clin Chem	2016	0.79
4	Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.	Eur Heart J	2017	0.77
5	Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.	Am Heart J	2016	0.75
6	Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes.	Am Heart J	2017	0.75